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Abstract: Degradable implant material for bone remodeling that corresponds to the 
physiological stability of bone has still not been developed. Promising degradable 
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materials with good mechanical properties are magnesium and magnesium alloys. 
However, excessive gas production due to corrosion can lower the biocompatibility.  
In the present study we used the polymer coating polycaprolactone (PCL), intended to 
lower the corrosion rate of magnesium. Additionally, improvement of implant geometry 
can increase bone remodeling. Porous structures are known to support vessel ingrowth and 
thus increase osseointegration. With the selective laser melting (SLM) process, defined 
open porous structures can be created. Recently, highly reactive magnesium has also been 
processed by SLM. We performed studies with a flat magnesium layer and with porous 
magnesium implants coated with polymers. The SLM produced magnesium was compared 
with the titanium alloy TiAl6V4, as titanium is already established for the SLM-process. 
For testing the biocompatibility, we used primary murine osteoblasts. Results showed a 
reduced corrosion rate and good biocompatibility of the SLM produced magnesium with 
PCL coating. 
Keywords: titanium implant; magnesium implant; polycaprolactone; poly-3-hydroxybutyrate; 
live cell imaging; osteoblast 
 
1. Introduction 
Autografts are commonly used for reconstruction of critical defects in maxilla-facial orthopedics, 
e.g., after accidents or tumor resections [1]. The bony material can be taken from intact bone, generally 
out of the hip. Therefore, the patient has to undergo surgery. Furthermore, the material itself is rare and 
the donor site often remains painful [2,3]. To avoid additional surgery, a material with appropriate 
conditions comparable to bone is needed. Many different resorbable materials for bone tissue 
engineering have been examined for this purpose, such as poly (lactic-co-glycolic acid) (PLGA)-based 
or poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx)-based scaffolds. However, there are 
no commercial implants that can meet physiological forces since the early beginning of implantation 
and desired degradation at the same time [4,5]. Materials that potentially can fulfill these demands are 
magnesium and magnesium alloys since they are promising resorbable robust metals [6,7]. They are 
biocompatible and the elastic modulus is close to that of bone. In the last few years, studies have 
shown good biocompatibility of magnesium-based implants [7]. However, the gas that this material 
produces is a major disadvantage, lowering the bone-implant contact. Therefore, different coatings or 
magnesium alloys are used to lower the corrosion rate [8]. After careful consideration, we decided to use 
the polymer coating polycaprolactone (PCL). This synthetically produced polymer showed good 
results in lowering the corrosion rate of magnesium [9,10]. Both magnesium and polymer are 
resorbable. Magnesium provides stability, while the polymer protects the implant from initial corrosion. 
Scaffold geometry can be used to enhance vascularization and consequently to achieve a good bony 
ingrowth. Recent studies have shown that porous scaffolds with 250 µm interconnected pores support 
angiogenesis [11,12]. For manufacturing the open porous structure, a selective laser melting (SLM) 
process was used. This rapid prototyping method offers a fast and patient individual implant 
production and titanium scaffolds using SLM is well established [13,14]. Recently, magnesium 
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scaffolds have been generated using SLM as well [15]. Nevertheless, resolution of 250 µm has not 
been achieved yet. The manufacturing process of magnesium had to be established in this study to 
achieve a higher resolution and thus a smaller pore size. A flat SLM-made magnesium structure on a 
titanium plate coated with PCL, later referred to as magnesium hybrid construct, was manufactured 
and used for the first time. Furthermore, a porous magnesium implant could be manufactured with the 
SLM process. For comparison purposes titanium was used, because of its suitability for the SLM 
process and as implant material. The cell behavior on the implant materials was examined using 
murine green fluorescent protein (GFP) osteoblasts in the live cell imaging (LCI), as recently shown [16]. 
Open porous magnesium structures generated by SLM and coated with PCL could be a way to 
overcome the deficiency in potential biodegradable and stable material for bone implants. The herein 
presented work should be a first step to overcome this deficiency. 
2. Results 
2.1. Manufacturing 
A titanium implant with 250 µm pore and strut size and a flat magnesium layer on titanium were 
produced by SLM and provided for in vitro experiments. A porous magnesium implant was 
manufactured of pure magnesium by SLM (Figure 1). The highest possible resolution achieved using 
the SLM process was 600 µm pore size. 
 
Figure 1. ESEM micrograph of magnesium implant manufactured by selective laser melting (SLM). 
2.2. In Vitro Corrosion Study 
Microscopic studies were performed to evaluate the in vitro corrosion-induced changes in surface 
morphology of the non-coated and polycaprolactone (PCL)-coated flat magnesium structures 
processed on a titanium plate. It was observed that the non-coated magnesium structures nearly 
disappeared in the short corrosion time of three weeks, while the PCL-coated structures seemed even 
to expand (Figure 2). 
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Figure 2. Representative ESEM micrographs of non-coated (A–D) and polycaprolactone 
(PCL)-coated (E–H) magnesium structures after different corrosion time intervals (A,E:  
0 days; B,F: 1 day; C,G: 3 days; D,H: 21 days). 
This observation could be confirmed by means of mass development analysis. The non-coated 
structures lost up to 2% of the initial total mass (SLM processed magnesium structure and titanium 
base structure), whereas the PCL-coated samples seemed to gain in mass (Figure 2F–H; Figure 3A). 
 
Figure 3. Corrosion-induced mass loss of non-coated and PCL-coated magnesium structures 
(A) and pH-value of surrounding medium (B) in Sørensen buffer (0.1 M, pH 7.4) at 37 °C. 
Data shown as means ± SD. 
To evaluate this result and to demonstrate the presence or absence of the PCL-coating during  
in vitro corrosion, the chemical composition of the initially PCL-coated magnesium structures was 
evaluated by EDX measurements. As shown in Table 1, the atomic percent (at%) of magnesium (Mg) 
and oxygen (O) increased, whereas the atomic percent of C decreased within the first 24 h. In the 
following corrosion time, no further modification of the chemical composition seemed to occur. 
Furthermore, the evolution of the pH values during the corrosion study was investigated. Thus, the 
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polymer specimens were immersed in buffer without intermediate medium change. For both,  
non-coated and coated samples, a constant increase in the pH-value was observed, which was, 
however, more prominent for non-coated (highest pH: 9.3; Figure 3B) than for coated specimens 
(highest pH: 8.1; Figure 3B). 
Table 1. EDX data on surface composition (atomic percent for the relevant elements Mg, 
O and C) of the PCL-coated magnesium structures after different corrosion intervals. 
Corrosion Time (Days) At% Mg At% O At% C 
0 0.06 34.08 65.86 
1 6.19 54.96 38.85 
3 6.33 52.75 40.92 
21 4.82 54.99 40.19 
2.3. Live Cell Imaging (LCI) of Magnesium Hybrid Construct Compared with the Titanium Implant 
Coated with Polycaprolactone (PCL) Seeded with Green Fluorescent Protein (GFP)-Osteoblast 
Comparing cell counts after the initial seeding of osteoblasts settled on the PCL coated titanium and 
on the hybrid construct (Figure 4A–C), no difference could be observed. 
 
Figure 4. Osteoblasts seeded on the magnesium hybrid construct on Day 1 (A), Day 3 (B) 
and Day 7 (C). Scale bars: 75 µm. 
After two days settling time, the cell count was significantly lower on the hybrid construct.  
We could also see a significant difference between the two scaffolds regarding the cell spreading area 
at the time point directly after seeding, as LCI for the PCL coated titanium implant was started after  
4 h cell settling time and for the hybrid construct, after 1 h. On Day 1–7 no difference occurred in the 
cell spreading area. The statistical analysis was performed using the unpaired t-test (p < 0.05). 
2.4. PCL-Thickness Measurement of Coated Magnesium Implant 
The magnesium implant was coated with PCL via a manual dip-coating process. Cross-section 
polishes of scaffolds were prepared to determine thickness of PCL coatings. The focus was put on the 
external coating, in order to evaluate the coating at the edge of the scaffold and on the internal coating 
with the 600 µm holes, which should enhance the angiogenesis (Figure 5). During dip coating, the 
direction of scaffold position was changed after each dip process in order to improve the coating 
homogeneity. For the external coating, a high thickness at the top, which decreases with increasing 
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deepness of scaffold, was observed. For the internal coating a uniform thickness over the whole cross 
section was evaluated (Table 2). 
 
Figure 5. ESEM image of a magnesium PCL implant. Two different zones of the PCL 
coating were analyzed, named the external coating and the internal coating. 
Table 2. Coating thickness depending on the position of measurement. 
Position PCL External Coating (µm) PCL Internal Coating (µm) 
Top 10.8 ± 1.2 1.2 ± 0.6 
Center 3.7 ± 3.5 1.3 ± 0.3 
Bottom 1 ± 0.1 1.4 ± 0.3 
2.5. LCI of Osteoblasts Seeded on Magnesium PCL and Titanium PCL Implants 
Two magnesium implants sunk to the well plate bottom and thus could not be used for the further 
experiment. An additional video could be performed for cells seeded on titanium implants but not on 
magnesium implant. 
Daily pictures of living cells successfully were imaged for both implant materials and were analyzed 
for development in cell spreading area and cell count of osteoblasts (Figure 6A,B). Comparing the 
results of cell spreading area and cell count, there was no difference between the two regression 
curves. The value of spreading area of cells settled on magnesium implant is higher than on titanium 
implants. Total cell numbers are higher on titanium implants in comparison with magnesium implants. 
A Statistical comparison test of the two regression coefficients, using an analysis of covariance, with  
a test of the interaction between the two implant materials and time with p < 0.05 was performed. 
PH-changes of culture medium with magnesium implants during the experiment never extended  
a difference of 0.3 in comparison with medium without magnesium implant. 
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Figure 6. Osteoblasts seeded on titanium and magnesium implant. The cell number 
development (A) and the cell spreading area development (B) over seven days were examined. 
3. Discussion 
The SLM process is achieved by wetting solidified material with liquid metal melted by laser 
radiation. Oxide layers impedes the wetting process and therefore have to be removed [17]. The 
titanium alloy TiAl6V4 shows a large solubility for oxygen [18], and it is assumed that oxides can be 
easily dissolved [19]. Thus, medical parts with an adequate surface quality can be manufactured [20]. 
Magnesium, in contrast, shows no solubility for oxygen [21] and also a very ductile oxide layer, which 
is difficult to break [22]. Using comparably high laser power, the oxide layer can be broken up and 
removed to facilitate the process. This results in large evaporations of magnesium, enforced by the low 
boiling point of magnesium. Also, regions of adhering sintered particles were found on the manufactured 
parts, decreasing the surface quality. Nevertheless, medical parts with an adequate surface quality can 
be manufactured by adjusting the scanning strategy and performing a chemical post treatment. 
In general, the high corrosion rate of magnesium can be lowered by coatings [23]. PCL-coating 
already showed reduced corrosion for extruded magnesium rods [10]. Other studies already showed 
good results for bone growth using PCL [24]. In addition, PCL offers us the opportunity to incorporate 
growth factors, as recently shown [25]. These components are the backbone of the diamond concept 
suggested by Giamond et al. [26]. 
PCL coating showed promising results for corrosion resistance of magnesium and thus can be used 
for bone tissue engineering. As magnesium is a promising material in the field of bone reconstruction, 
the PCL-coated magnesium implant has great potential [7]. 
Therefore, a PCL coating was used with the intention of lowering the corrosion rate of the  
SLM-produced magnesium. A corrosion study with PCL-coated flat magnesium structures fixed on a 
titanium support (magnesium hybrid construct) was performed. In comparison to non-coated samples, 
PCL-coated samples gained in mass and increased atomic percentage of Mg and O, whereas the atomic 
percentage of C decreased within the first 24 h. This suggests the formation of magnesium hydroxide 
by water interpenetration within the polymer coating [9]; protecting complete wash off of the flat 
magnesium structure from the titanium support, which is the case for non-coated samples. 
Furthermore, the magnesium hydroxide layer seems to function as passivation of the magnesium 
structure since no further alteration of the surface chemical composition was observed during the 
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following corrosion time. The more prominent increase of the pH-values for non-coated samples 
supports this hypothesis. Generated hydroxyl-ions during magnesium corrosion are thus kept longer on 
the surface of coated samples, while they are released into the surrounding media for non-coated 
samples resulting in greater pH. In conclusion, the biodegradable PCL-coating allows stabilization of 
the magnesium structure and is hence a promising candidate for alteration of the corrosion rate of 
magnesium-based implants. 
The thickness of the PCL film on porous magnesium scaffolds seems to be inhomogeneous regarding 
the external coating. Some parts of the coating are very thin (under 1 µm), which have to be improved 
in order to ensure degradation decrease in the used scaffold structure for degradation study. For the 
internal coating, a uniform coating thickness for the holes were observed, only the standard deviation 
is marginally higher at the top of the cross-section polish. In order to improve the uniformity of these 
coatings, a further optimization of the magnesium scaffolds surface morphology and the coating 
procedures are necessary. Nevertheless, dip coating, in contrast to spray coating, seems to be suitable 
for porous magnesium scaffolds, as it was possible to coat the whole scaffold without closing the 
holes. However, for the simple geometry used for the magnesium hybrid construct, it turns out that the 
spray coating seems to be more suitable. 
As the PCL-coating showed reduced corrosion and thus reduced pH-changes, it could be used in the 
cell culture. Using LCI, it was demonstrated that osteoblasts initially showed similar seeding densities 
for magnesium and titanium implants. After two days, cell numbers decreased on the magnesium 
hybrid construct. As gas production is part of the magnesium corrosion process, it is suggested that 
cells could be removed from the surface without effecting viability of the remaining cells; furthermore, 
similar cell morphology was found on both implants, the titanium implant and magnesium hybrid 
construct. This was confirmed by the cell spreading area, which showed a flattened cell shape from  
Day 1 to Day 7. 
LCI of porous magnesium PCL implants obtained similar results. Nevertheless, due to the corrosion 
process, two of the four implants sunk to the well bottom and thus were eliminated because cells were 
be able to migrate towards the ground. Comparing the results of the development for cell spreading 
area and cell count over seven days, both magnesium PCL implant and titanium PCL implant showed 
equal cell behavior over time, indicated by equal slope of the regression curves. Spreading area of cells 
settled on magnesium implant was higher than on titanium implant. This could be due to the settings of 
the assay, as the fluorescence intensity was not equal due to different light reflection of the materials. 
Total cell number was fewer on magnesium implant. It is assumed that the corrosion process impeded 
cell settling, as mentioned before. 
Often, magnesium is represented as supernatant to cells attached to the well plate bottom in indirect 
cell culture experiments [27,28]. The influence of adherence strength to study cells is missing when 
using indirect methods. Other studies showed growing cells in LCI settled at well plate bottoms when 
exposed to degraded products of magnesium [29]. Especially for magnesium, it is highly important to 
monitor cells directly on the implant’s surface. Due to diffusion, the chemical and physical conditions 
directly at the magnesium surface, in comparison to the supernatant of dissolved magnesium solution, 
are different. The pH on the surface could be much greater than the average pH of the solution [30]. 
Direct assays are performed by cell fixation and thus show one time point only [31–33].  
The established LCI assay has the advantage of direct assays and moreover one can follow living cells 
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over time (Video S1). Thus, we were able to compare cell settling on the magnesium hybrid construct 
and on the titanium implant coated with PCL. Nevertheless, no video could be recorded of the porous 
magnesium PCL implant, as gas production of the magnesium implant obstructed the view for  
cell imaging. 
Open porous magnesium especially has been considered as a potential means of treating bony 
defects [34,35]. So far, magnesium structures having interconnected pores with 250 µm have not been 
made by SLM. Further investigations on SLM of magnesium and magnesium alloys showed that the 
use of magnesium alloys can significantly improve the SLM process. 
However, the establishment of novel in vitro methodologies for the analyses of magnesium 
constructs remains key, as recent studies revealed major differences between in vitro and in vivo 
results limiting the predictive power of conventional in vitro systems for in vivo scenarios in  
general [36–38]. 
4. Experimental Section 
4.1. Selective Laser Melting (SLM) of Titanium and Magnesium Implants 
The titanium implants were manufactured by SLM by SLM Solutions GmbH, Luebeck, Germany 
from a TiAl6V4 titanium alloy. 
The magnesium implants were manufactured by SLM from pure magnesium powder Atoultra 325 
provided by SFM SA (Société pour la Fabrication du Magnésium), Martigny, Switzerland. An 
SLM125HL machine system equipped with an overpressure capable process chamber provided by SLM 
Solutions GmbH, Germany was used to process this material. Using a laser power of 100 W, a scan 
speed of 3000 mm/s and an adapted hatch strategy, scaffolds with a homogenous surface quality were 
manufactured. Nevertheless, porous magnesium implants had to be post treated by a chemical 
deburring process in order to remove adhering particles and to gain smooth surfaces for sterilization 
and polymer coating. Micrographs of porous magnesium implant were obtained by SEM (FEI Quanta 
400 FEG, FEI Company, Hillsboro, OR, USA). 
4.2. In Vitro Corrosion Study 
For investigating the in vitro corrosion behavior of magnesium structures prior to and after polymer 
coating, coated and non-coated samples (n = 3 samples per time point) were placed in a test tube 
containing 2 mL of Sørensen buffer (0.1 M, pH 7.4) and kept at 37 °C under gentle shaking.  
Samples were periodically removed, washed with distilled water and dried in a vacuum before 
analysis. The buffer solution was exchanged twice per week. 
4.2.1. Spray-Coating Process for Application of Polymeric Coatings to Flat Magnesium Structures for 
the in Vitro Corrosion 
Flat magnesium structures were coated with PCL by means of a spray-coating process for which a 
specially designed spray-coating device was developed by the Institute for Implant Technology and 
Biomaterials (IIB e.V., Rostock, Germany). A PCL solution with concentrations of 1.53 g/L of PCL 
dissolved in chloroform was used. For each structure, a coating with an absolute mass of 300 µg was 
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applied. After coating, the magnesium structures were dried in a vacuum at 40 °C for 24 h. The coating 
mass of the dried PCL coatings was determined by using a Mettler Toledo UMX 5 Ultra-micro 
Balance (Mettler-Toledo GmbH, Giessen, Germany). 
4.2.2. Gravimetry 
To evaluate the magnesium corrosion by determining mass loss, the washed and dried samples  
(n = 3 samples per time point) were weighed using a special accuracy balance (UMX 5 Mettler Toledo, 
Greifensee, Switzerland). The mass loss was determined as the mass at time t divided by the initial 
mass multiplied by 100. 
4.2.3. PH Value Measurement 
Polymer samples (n = 3) were stored in 2 mL of Sørensen buffer (0.1 M, pH 7.4) at 37 °C under 
gentle shaking and the pH values were measured at different time points by means of a pH meter 
(Seven Easy pH Meter S20, Schwerzenbach, Switzerland). 
4.2.4. Scanning Electron Microscopy and EDX Measurements 
The surface morphology and the chemical surface composition of the PCL-coated magnesium 
structures were assessed after the different corrosion intervals (1, 3, and 21 days, respectively),  
and compared to uncoated controls using environmental scanning electron microscopy and  
EDX-measurements. Conditions as described above were applied. 
4.3. Murine GFP-Osteoblast and Murine Osteoblast Isolation 
Cells were isolated using adult C57Bl6 mice or GFP*C57Bl6 mice as described before [39]. Mouse 
calvarium was minced carefully into small pieces using 200 U/mL collagenase II (Cell Systems, 
Troisdorf, Germany) in Hanks’ Balanced Salt Solution (HBSS, Biochrom, Berlin, Germany) Calvarias 
of ten mice were pooled and 5 mL collagenase solution was added at 37 °C for 10 min and repeated 
five times. Only supernatant of the previous three steps was used for further centrifugation (1200 rpm, 
7 min). After two washing steps with culture medium, the cells were plated and incubated at 37 °C and 
8.5% CO2. 
For further cell culture, Dulbecco’s Modified Eagle Medium (DMEM, Biochrom, Berlin, Germany) 
and 10% fetal calf serum (FCS), 20 mM Hepes, 1000 IU/mL penicillin and 0.1 mg/mL streptomycin 
(all Biochrom, Berlin, Germany) were used. Media changing was performed every third day until they 
were confluent. 
For all further cell experiments culture medium was DMEM with 10% FCS. Conditions of 
incubation were 37 °C and 5% CO2. 
4.4. PCL Coating of Magnesium PCL and Titanium PCL Implant 
After purification of magnesium scaffolds in isopropanol, a manual dip-coating process, for which a 
specially designed sample holder was developed, was established. Two milliliters of polymer solutions 
with a concentration of 0.8% (w) of PCL in chloroform were used for each scaffold and filled into the 
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dipping tanks adapted for the application. The dipping process was repeated four times with 
intermediate drying for 10 min at 23 ± 2 °C after each dipping process. Finally, the coated Magnesium 
scaffolds were dried under vacuum at 40 °C for 24 h. 
The surface morphology of the PCL coated scaffolds was assessed at different sites in order to test 
for complete surface coverage and to compare with the non-coated control scaffolds using an 
environmental scanning electron microscopy (Quanta FEG 250, FEI, Eindhoven, The Netherlands) 
equipped with an energy-dispersive X-ray (EDX) analysis unit. The scaffolds were fixed with 
conductive tape on aluminum trays and the scanning electron micrographs were taken at 50 Pa 
pressure in a moisturized atmosphere and an accelerating high voltage of 10 kV. The presence or 
absence of the polymeric coatings was assessed by EDX measurements performed at the beam 
entrance of the electron microscope. For element (Mg, C) determination, the spectra of the fibers 
bombarded with electrons were analyzed. 
4.5. PCL-Thickness Measurement of Coated Magnesium Implant 
Samples were covered with a 20 nm thin gold film before embedding using Agar Sputter Coater 
(Plano GmbH, Wetzlar Germany). Scaffolds were embedded in epoxy resin (Epo Color™ Epoxy 
Resin with Epo Colour™ Epoxy Hardener, 5:1, Buehler, Waukegan, IL, USA). Cross-section polishes 
were prepared using a TegraPol-15 (Struers GmbH, Willich, Germany) till scratch-free. The thickness 
of polymer coating was determined using Microscopy (Axioskop, Carl Zeiss AG, Germany). 
4.6. Live Cell Imaging (LCI) 
4.6.1. LCI of Titanium Implant Seeded with GFP-Osteoblast 
Titanium scaffolds coated with PCL were placed in a 96 well plate filled with 150 µL DMEM and 
10% FCS. GFP-osteoblasts of passage 9 (P 9) were added gently on the top of the scaffolds at a 
concentration of 2.5 × 104 cells/150 μL medium in triplicate. After 5 h incubation period at 37 °C and 
5% CO2, the implants were turned upside down to visualize the cells in the inverse microscope, and 
put into new wells that were prepared with purpose-built Teflon-slices used for lifting the scaffolds to 
create a gap between cells growing on the scaffolds and the bottom of the culture plates. Then, 
proliferation and motility of the cells could be observed by Live Cell Imaging Microscope (DMI6000 
B, Leica Microsystems, Wetzlar, Germany) over seven days with the program LAS AF 2.6.0.  
For every implant, we took a picture of the same position every 15 min. A constant temperature of  
37 °C was achieved by using a heating unit and CO2 atmosphere. 
Cells at the same concentration without scaffolds and Teflon-slices were used as control. Cell count 
and cell size were examined by Wimasis Image Analysis GmbH. 
4.6.2. LCI of Magnesium Hybrid Construct and Magnesium PCL Implant Seeded with GFP-Osteoblast 
After establishing LCI of titanium implants, we used magnesium implants seeded with  
GFP-osteoblasts. Three magnesium hybrid constructs and five magnesium PCL implants were 
incubated in a 6-well plate for 24 h using culture medium (DMEM with 10% FCS) and five 
magnesium PCL implants were incubated for 48 h. Then GFP-osteoblasts were seeded in the same 
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concentration as before with 78,125 cells/1 cm2 surface area onto the scaffolds and as control on the 
well plate. After one hour of cell adhesion, implants were placed in the scaffold holder created for the  
6-well plate. The scaffold holder was prepared to ensure a good gas exchange so that the pH value was 
not partially increased. Further examination was done as described above, but only for one construct 
each. One magnesium hybrid construct and one magnesium PCL implant was imaged at the same 
position for video examination. Imaging of different implants would have led to medium movement, 
which would have resulted in faster magnesium corrosion. Therefore, the other constructs were imaged 
at five different random fields every day. Cell count and cell size were examined by Wimasis Image 
Analysis GmbH, Munich, Germany. PH values were assessed for the surrounding medium of the 
magnesium implants. 
4.7. Statistical Analysis 
Statistical analyses of data were performed using SAS® software, Version 9.3 (SAS Institute Inc., 
Cary, NC, USA). The experimental data were shown as mean ± standard deviation. The p-value <0.05 
was considered statistically significant. 
5. Conclusions 
Magnesium implants were produced by SLM and a defined open porous structure with 600 µm was 
possible. PCL-coating could reduce the corrosion rate of magnesium. Nevertheless, depending on the 
location, the coating thickness varied and could be improved. Porous titanium implants coated with 
polymers as well as magnesium hybrid constructs and porous magnesium PCL implants could 
successfully be vitalized and examined with LCI for one week. SLM-produced magnesium, coated 
with PCL is a promising bone implant material and should be examined in vivo. 
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